Curran, Michael A <br/><br/>
Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors.  [electronic resource] 

 -  Cancer research  Oct 2009 
 - 7747-55 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-08-3289  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--immunology<br/>Adjuvants, Immunologic--pharmacology<br/>Animals<br/>Antigens, CD--immunology<br/>CD4-Positive T-Lymphocytes--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>CTLA-4 Antigen<br/>Cancer Vaccines--immunology<br/>Carboxypeptidases A--pharmacology<br/>Cricetinae<br/>Dendritic Cells--immunology<br/>Drug Synergism<br/>Granulocyte-Macrophage Colony-Stimulating Factor--pharmacology<br/>Killer Cells, Natural--immunology<br/>Male<br/>Melanoma, Experimental--immunology<br/>Membrane Proteins--immunology<br/>Mice<br/>Mice, Inbred C57BL<br/>Prostatic Neoplasms--immunology<br/>T-Lymphocytes, Regulatory--immunology